By Elric Langton | Updated 21st August 2021
SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, has today provided a business update including an update on plans for commercialisation of AxisBiotix-Ps™ as committed to in the announcement of 26 May 2021.
I and Stuart Ashman, the CEO of SkinBioTherapeutics had a chat that of…